Malignancy workup, including tumor biomarkers (Carcinoembryonic Antigen (CEA), Cancer Antigen 19‐9 (CA19‐9), and Cancer Antigen 125 (CA125)), spiral chest, abdominal, and pelvic Computed Tomography (CT) scans, mammography, gynecologic examination, and occult blood test, was negative. This evidence concerns the gene MUC16 and neoplasm.